Arifa S. Khan, PhD U.S. FDA

Dr. Arifa S. Khan is Head, Molecular Retrovirology Unit, Division of Viral Products, Office of Vaccines Research and Review, in the Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. She moved her retrovirus reseach program from NIAD/NIH to CBER in 1991, where she is currently leading efforts for applications of high-throughput sequencing for endogenous retrovirus and adventitious virus detection for safety evaluation of biologics. Her primary regulatory responsibilities include viral vaccines, including HIV-1, influenza virus and SARS-COV-2. Dr. Khan also provides expert consultation on viral safety and testing to OTAT/CBER and CDER. She has been involved in licensure of several viral vaccines and development of FDA, ICH, PHS, USP, and WHO documents. Dr. Khan obtained her Ph.D. in Microbiology from the George Washington University, Washington, D.C. She has authored more than 100 publications.